Siren Biotechnology

Operator of a biotech company intended to provide a gene therapy for a variety of cancer treatments. The company's therapy integrates adeno-associated virus-based gene therapy with immunotherapy, deli...

Healthcare

San Francisco, CA, United States

Founded 2020

9 employees

Website

Valuation

Share Price

N/A

Total Raised

$25.6M

Last Round

N/A

Investors

+17 other investors

View all 17 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Siren Biotechnology's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required